Back to search
FDAFDA · Food and drugs·Recall number D-0327-2021

Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080

Published April 14, 2021 · Recall initiated: March 25, 2021

Summary

FDA records drug Class II recall D-0327-2021, published April 14, 2021 and initiated March 25, 2021. Recalling firm: Cosette Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: a) 30 mL: 7724 b) 60 mL: 8064 bottles; Lot: a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviaitons

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cosette Pharmaceuticals, Inc.
Distributor
Nationwide in the US
Lot
a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080 recalled?

Yes. FDA published recall D-0327-2021 on April 14, 2021. Reported hazard: CGMP Deviaitons

What should I do if I have this product?

Voluntary: Firm initiated · Letter